Allergy & Clinical Immunology News
- Bausch + Lomb Buys Novartis Drugs for $1.75 Billion
- ADA 2023 33% of Type 1 Diabetes Patients Insulin-Free With Stem Cells
- Alert FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes
- Systemic Sclerosis Without Skin Fibrosis Can Still Be Severe
- Physicians Accuse Hospital Chain of Fraud and Overbilling
- SJS/TEN: Study Addresses Issues in Identifying Culprit Drug
- Woman Jailed for Refusing TB Treatment or Isolation
- CAR T-Cell Therapy May Treat Antisynthetase Syndrome
- Merck Accused of Downplaying Evidence of Drug’s Brain Impact
- EU Panel Backs New Pre-Filled Pen for Injecting Tralokinumab
- Promising Early Results for Goflikicept in Pericarditis
- Study Identifies Possible Pathogenesis of Rare Skin Disorder
- New Law Allows International Graduates to Skip US Residency
- Study Reveals How Immune System of Astronauts Breaks Down
- Low-Dose Colchicine Approved for CVD: Now What?
- No Link Between PPIs and Dementia in New Study
- You Can Dismiss a Difficult Patient, but Should You?
- Mixed Results for Drug in Eosinophilic Gastritis
- Proposal to Cap Part B Pay on Some Drugs Draws Opposition
- Cutting-Edge Nasal Tech Could Usher in a New Era of Medicine